Hospira Heparin Sodium, 1,000 USP Heparin Units/500 mL In 0.9% Sodium Chloride Injection, Recalled: AttorneyOne Monitors and Keeps Consumers Informed

Share Article

On September 12, Hospira, Inc. announced the recall of one lot of Heparin Sodium, 1,000 USP Heparin Units/500 mL (2 USP Heparin Units/mL), in 0.9% Sodium Chloride Injection, 500 mL due to particulate matter. In light of this news, AttorneyOne, a recognized authority on law, updated the website providing detailed information to consumers.

Hospira Heparin Sodium Recalled

Hospira Heparin Sodium Recalled

Anyone with an existing inventory should stop use and distribution and quarantine the product immediately

AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information from the FDA on Heparin Sodium.

Hospira, Inc. announced on September 12, that one lot of Heparin Sodium, 1,000 USP Heparin Units/500 mL (2 USP Heparin Units/mL), in 0.9% Sodium Chloride Injection, 500 mL is recalled due to particulate matter.

FDA’s reason for the recall a confirmed customer report of particulate in a single unit identified by Hospira as human hair. If particulate matter is injected it may cause low-level allergic response, phlebitis, or local inflammation. Capillaries may become occluded posing an increased risk for patients with preexisting condition of trauma or other medical condition that adversely affects the microvascular blood supply.

The affected lot is Heparin Sodium, 1,000 USP Heparin Units/500 mL (2 USP Heparin Units/mL), in 0.9% Sodium Chloride Injection, 500 mL, NDC 0409-7620-03 Lot 41-046-JT with expiration date of 01NOV 2015.

Taking into consideration the latest developments, AttorneyOne.com monitor daily and update the website providing accurate information on all relevant FDA safety alerts. Sean Burke, director of Media Relations at AttorneyOne.com, adds “we are determined to keep an eye on FDA announcements concerning Heparin Sodium and inform the public. For that reason", he continues, "our focus should squarely fall on investigating these safety alerts and getting the word out.”

As the FDA recommends “Anyone with an existing inventory should stop use and distribution and quarantine the product immediately.” And the Agency notes “In addition, customers should inform potential users of this product in their organizations of this notification.”

AttorneyOne.com has further information on Heparin Sodium at the website including the latest major drug, medical products, and food law news.

Headquartered in San Diego, CA Attorney One was founded in 2004 and is not a law firm. They offer a nationwide legal service which helps consumers find the best representation for their legal needs. You can learn more about Attorney One at our website http://www.attorneyone.com. You can also find us on Facebook at http://www.facebook.com/AttorneyOne. Checkout earlier news from us at http://www.prweb.com/releases/2014/09/prweb12168281.htm

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Sean Burke
Attorney One
+1 877-230-7343
Email >
@Attorney_One
Follow >
Visit website